Literature DB >> 20122288

Identity of mysterious CD4+CD25-Foxp3+ cells in SLE.

David A Horwitz.   

Abstract

Various abnormalities in CD4+CD25+ regulatory T cells (Tregs) in systemic lupus erythematosus (SLE) include increased Foxp3+ cells that are CD25 negative. Barring methodological technical factors, these cells could be atypical Tregs or activated non-Treg CD4+ cells that express Foxp3. Two groups have reached opposite conclusions that could possibly reflect the subjects studied. One group studied untreated new-onset SLE and suggested that these T cells were mostly CD25-Foxp3+ non-Tregs. The other group studied patients with long-standing disease and suggested that these cells are mostly dysfunctional Tregs. A third group reported increased Foxp3+CD4+CD25dim rather than CD25- cells in active SLE and these were also non-Tregs. Thus, it is likely that not all Foxp3+ T cells in SLE have protective suppressive activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20122288      PMCID: PMC2875622          DOI: 10.1186/ar2894

Source DB:  PubMed          Journal:  Arthritis Res Ther        ISSN: 1478-6354            Impact factor:   5.156


  11 in total

Review 1.  Regulatory T cells in the control of host-microorganism interactions (*).

Authors:  Yasmine Belkaid; Kristin Tarbell
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

2.  Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development.

Authors:  Marc A Gavin; Troy R Torgerson; Evan Houston; Paul DeRoos; William Y Ho; Asbjørg Stray-Pedersen; Elizabeth L Ocheltree; Philip D Greenberg; Hans D Ochs; Alexander Y Rudensky
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-14       Impact factor: 11.205

3.  TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice.

Authors:  Kazuhiko Nakamura; Atsushi Kitani; Ivan Fuss; Aasta Pedersen; Naohiko Harada; Hajime Nawata; Warren Strober
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

4.  Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus.

Authors:  B Zhang; X Zhang; F L Tang; L P Zhu; Y Liu; P E Lipsky
Journal:  Ann Rheum Dis       Date:  2008-01-16       Impact factor: 19.103

5.  Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells.

Authors:  Keli L Hippen; Paul Harker-Murray; Stephen B Porter; Sarah C Merkel; Aryel Londer; Dawn K Taylor; Megan Bina; Angela Panoskaltsis-Mortari; Pablo Rubinstein; Nico Van Rooijen; Tatiana N Golovina; Megan M Suhoski; Jeffrey S Miller; John E Wagner; Carl H June; James L Riley; Bruce R Blazar
Journal:  Blood       Date:  2008-07-21       Impact factor: 22.113

6.  Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus.

Authors:  Michael Bonelli; Anastasia Savitskaya; Carl-Walter Steiner; Eva Rath; Josef S Smolen; Clemens Scheinecker
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

7.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells.

Authors:  Weihong Liu; Amy L Putnam; Zhou Xu-Yu; Gregory L Szot; Michael R Lee; Shirley Zhu; Peter A Gottlieb; Philipp Kapranov; Thomas R Gingeras; Barbara Fazekas de St Groth; Carol Clayberger; David M Soper; Steven F Ziegler; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

Review 8.  Regulatory T cells in systemic lupus erythematosus: past, present and future.

Authors:  David A Horwitz
Journal:  Arthritis Res Ther       Date:  2008-11-14       Impact factor: 5.156

9.  Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta.

Authors:  Suchita Nadkarni; Claudia Mauri; Michael R Ehrenstein
Journal:  J Exp Med       Date:  2007-01-02       Impact factor: 14.307

10.  Are CD4+CD25-Foxp3+ cells in untreated new-onset lupus patients regulatory T cells?

Authors:  Hua-xia Yang; Wen Zhang; Li-dan Zhao; Yang Li; Feng-chun Zhang; Fu-lin Tang; Wei He; Xuan Zhang
Journal:  Arthritis Res Ther       Date:  2009-10-12       Impact factor: 5.156

View more
  34 in total

1.  T cells expressing the lupus susceptibility allele Pbx1d enhance autoimmunity and atherosclerosis in dyslipidemic mice.

Authors:  Wei Li; Ahmed S Elshikha; Caleb Cornaby; Xiangyu Teng; Georges Abboud; Josephine Brown; Xueyang Zou; Leilani Zeumer-Spataro; Brian Robusto; Seung-Chul Choi; Kristianna Fredenburg; Amy Major; Laurence Morel
Journal:  JCI Insight       Date:  2020-06-04

2.  Dendritic cell-specific disruption of TGF-β receptor II leads to altered regulatory T cell phenotype and spontaneous multiorgan autoimmunity.

Authors:  Rajalakshmy Ramalingam; Claire B Larmonier; Robert D Thurston; Monica T Midura-Kiela; Song Guo Zheng; Fayez K Ghishan; Pawel R Kiela
Journal:  J Immunol       Date:  2012-09-12       Impact factor: 5.422

3.  Altered frequency and phenotype of CD4+ forkhead box protein 3+ T cells and its association with autoantibody production in human immunodeficiency virus-infected paediatric patients.

Authors:  R J Argüello; J Balbaryski; G Barboni; M Candi; E Gaddi; S Laucella
Journal:  Clin Exp Immunol       Date:  2012-05       Impact factor: 4.330

4.  Gut microbiota dysbiosis and altered tryptophan catabolism contribute to autoimmunity in lupus-susceptible mice.

Authors:  Seung-Chul Choi; Josephine Brown; Minghao Gong; Yong Ge; Mojgan Zadeh; Wei Li; Byron P Croker; George Michailidis; Timothy J Garrett; Mansour Mohamadzadeh; Laurence Morel
Journal:  Sci Transl Med       Date:  2020-07-08       Impact factor: 17.956

5.  Broadened T-cell repertoire diversity in ivIg-treated SLE patients is also related to the individual status of regulatory T-cells.

Authors:  Nuno Costa; Ana E Pires; Ana M Gabriel; Luiz F Goulart; Clara Pereira; Bárbara Leal; Ana C Queiros; Wahiba Chaara; Maria F Moraes-Fontes; Carlos Vasconcelos; Carlos Ferreira; Jorge Martins; Marina Bastos; Maria J Santos; Maria A Pereira; Berta Martins; Margarida Lima; Cristina João; Adrien Six; Jocelyne Demengeot; Constantin Fesel
Journal:  J Clin Immunol       Date:  2012-10-14       Impact factor: 8.317

Review 6.  [Regulatory T-cells in systemic lupus erythematosus. IL-2 is decisive for loss of tolerance].

Authors:  K Ohl; K Tenbrock
Journal:  Z Rheumatol       Date:  2016-04       Impact factor: 1.372

Review 7.  FoxP3 Expression in Macrophages, Cancer, and B Cells-Is It Real?

Authors:  Zahava Vadasz; Elias Toubi
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

Review 8.  The Role of STAT Signaling Pathways in the Pathogenesis of Systemic Lupus Erythematosus.

Authors:  Aleš Goropevšek; Marija Holcar; Tadej Avčin
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

9.  Significant association of CD4+CD25+Foxp3+ regulatory T cells with clinical findings in patients with systemic lupus erythematosus.

Authors:  Xiaofan Yang; Weiwen Wang; Juan Xu; Ming-Shun Zhang; Huanping Mei; Youxuan Shen; Miao-Jia Zhang; Xiaohui Ji; Huijuan Wang
Journal:  Ann Transl Med       Date:  2019-03

10.  Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus.

Authors:  Zhi-Wei Lai; Rebecca Borsuk; Ashwini Shadakshari; Jianghong Yu; Maha Dawood; Ricardo Garcia; Lisa Francis; Hajra Tily; Adam Bartos; Stephen V Faraone; Paul Phillips; Andras Perl
Journal:  J Immunol       Date:  2013-08-02       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.